CHINET 2012 antimicrobial rsistance surveillance in Stenotrophomonas maltophilia across China
Xiaoman AI,Yunjian HU,Zhidong HU,Quan LI,Ziyong SUN,Zhongju CHEN,Yingchun XU,NG ZHA,NG WA,Demei ZHU,Fupin HU,Yuxing NI,Jingyong SUN,Chao ZHUO,Danhong SU,Yuanhong XU,Jilu SHEN,Yunsong YU,Jie LIN,Bin SHAN,Yan DU,Zhaoxia ZHANG,Ping JI,Yunzhuo CHU,L WEI,U W,A W,Hong ZHANG,Jing KONG
DOI: https://doi.org/10.3969/j.issn.1009-7708.2014.06.006
2014-01-01
Abstract:Objective To investigate the antimicrobial resistance of clinical Stenotrophomonas maltophilia isolates from 15 hospitals in several regions of China during 2012 . Methods Fifteen representative general hospitals were involved in this program .Bacterial susceptibility testing was carried out by means of a unified protocol using Kirby‐Bauer method and minimum inhibitory concentration ( M IC ) determination .The results were analyzed according to the 2012 CLSI breakpoints .Results Most (97 .5% ) of the 2 156 clinical strains of S . maltophilia were isolated from inpatients .Only 2 .5% of the isolates were from outpatients . About 65 .4% (1 410/2 156) of the strains were isolated from old patients at least 60 years of age ,and only 5 .3% (115/2 156) were from patients of 18 years old or younger .Sputum and respiratory tract secretion were the most common specimen source , accounting for 82 .1% .And 3 .8% of the isolates were from blood ,abdominal fluid and other sterile body fluids .About 10 .0% ,10 .5 % ,3 .8 % and 24 .4% of the S . maltophilia strains were resistant to trimethoprim‐sulfamethoxazole , levofloxacin , minocycline , and cefoperazone‐sulbactam , respectively . Conclusions Majority of S . maltophilia strains are isolated from respiratory tract specimens of inpatients .Such strains are usually isolated from old patients at lease 60 years of age .The S . maltophilia strains are intrinsically resistant to most antibacterial agents , but still show low resistance to trimethoprim‐sulfamethoxazole ,levofloxacin and minocycline .Antimicrobial therapy for S .maltophiliastrains should be based on the results of antimicrobial susceptibility testing .